What are the DSM-5 criteria for catatonia? The answer is concise: catatonia is diagnosed when three or more of twelve specified psychomotor features are present — stupor, catalepsy, waxy flexibility, mutism, negativism, posturing, mannerism, stereotypy, agitation, grimacing, echolalia, and echopraxia — plus a code that tells you which disorder the catatonia is attached to: a schizophrenia spectrum disorder, a mood disorder, another mental disorder, or a medical condition.
That 3-of-12 rule makes catatonia one of the most testable diagnoses in psychiatry, and one of the most missed at the bedside. This guide walks through each of the twelve features as it actually looks on the ward, the DSM-5-TR coding and specifiers, the subtypes that kill (malignant and excited catatonia), the under-recognition problem, and the lorazepam challenge that is simultaneously a diagnostic test and a treatment. You will finish with the complete feature table — the single highest-yield revision item for MRCPsych and USMLE-style questions.
Catatonia: recognition before criteria
Catatonia is a syndrome of disturbed motor behaviour that sits at the interface of psychiatry, neurology, and acute medicine. It appears across DSM-5-TR and ICD-11, classically in catatonia associated with another mental disorder (schizophrenia, bipolar disorder, major depression), but also as catatonia due to another medical condition — after stroke, in autoimmune encephalitis, with anti-NMDA receptor antibodies, in neuroleptic malignant syndrome, and in metabolic or toxic states.
Under-recognition is the rule rather than the exception. Case series have found that a substantial minority of catatonic patients are initially misdiagnosed — as depression with psychomotor retardation, as "negative symptoms" of schizophrenia, as refusal of care, or as a functional neurological presentation. Because the consequences of missing it include prolonged episodes, complications of immobility (dehydration, pneumonia, venous thromboembolism), malignant catatonia, and avoidable mortality, the syndrome deserves the same urgency you would give a changing mental state in an older medical inpatient.
DSM-5 criteria for catatonia: 3 of 12 features
DSM-5 simplified catatonia diagnosis considerably compared with its predecessors: there is no required duration threshold within the criteria list — you need three (or more) of the following twelve features, and the features should dominate the clinical picture. DSM-5-TR retains this structure — see the APA's DSM-5-TR resources for the full criteria text. Here is each feature with its bedside description, grouped for study:
| # | DSM-5 feature | What it looks like at the bedside |
|---|---|---|
| 1 | Stupor | Motionless, unresponsive state; minimal or no response to stimuli — but rousable enough not to meet coma criteria |
| 2 | Catalepsy | Passive holding of a posture: an examiner positions a limb and it stays there indefinitely |
| 3 | Waxy flexibility | Limbs move with continuous, wax-like resistance — like bending a warm candle, distinct from the uniform drag of lead-pipe rigidity |
| 4 | Mutism | No verbal response despite being awake and apparently attending |
| 5 | Negativism | Motivated resistance or no response to instructions — opposes or ignores what is asked, moves away from the examiner |
| 6 | Posturing | Spontaneous maintenance of a position against gravity — arm held aloft for minutes, arched back, tripod stance |
| 7 | Mannerism | Purposeful but exaggerated or distorted gestures — an over-precise, theatrical version of a normal movement |
| 8 | Stereotypy | Repetitive, apparently meaningless motor acts — rocking, finger-waving, repeated facial grooming loops |
| 9 | Agitation | Motor excitement not clearly caused by external stimuli — the hyperactive end of the syndrome (excited catatonia) |
| 10 | Grimacing | Rapid, involuntary facial grimacing and eye-opening patterns |
| 11 | Echolalia | Repetition of another person's words |
| 12 | Echopraxia | Repetition of another person's movements |
A study-friendly grouping: stupor spectrum (stupor, mutism, negativism), posture/passivity (catalepsy, waxy flexibility, posturing), repetitive movement (mannerism, stereotypy, grimacing), excitement (agitation), and imitation (echolalia, echopraxia). Three from any columns count — examiners like vignettes where the patient is mute, holds an arm up, and echoes your words: that is three, which is diagnostic.
Coding and specifiers: whose catatonia is it?
DSM-5 provides distinct pathways, and getting the code right is a common exam discriminator:
- Catatonia associated with another mental disorder (F06.1): use with schizophrenia spectrum and other psychotic disorders, bipolar and related disorders, and depressive disorders when the catatonia criteria are met — record the underlying disorder first, then the catatonia specifier.
- Catatonia due to another medical condition (F06.1): when a physiological cause is established — stroke, autoimmune encephalitis, NMS, metabolic derangement, substance/medication effect.
- Specify the course: DSM-5 allows indication of a single episode versus recurrent episodes.
Phenotypic variants worth knowing: excited catatonia (agitation, combativeness, echopraxic mimicry), the akinetic/stuporous form that dominates vignettes, and malignant catatonia — the lethal cluster of autonomic instability (fever, tachycardia, blood-pressure swings) with rigidity and altered consciousness, which overlaps clinically with neuroleptic malignant syndrome. NMS can reasonably be conceptualised as a drug-induced malignant catatonia, which is why the management logic converges: stop dopamine antagonists, treat with benzodiazepines or ECT, and monitor in a high-acuity setting.
Exam trap: mutism and stupor are not "just negative symptoms"
A withdrawn, immobile, mute patient with a schizophrenia diagnosis is described as showing "negative symptoms" or "depressive retardation" — but if three catatonia features are present, it is catatonia, and the management changes completely. Test the motor syndrome directly (limb positioning for waxy flexibility, watching for echopraxia) and remember: the lorazepam challenge is both diagnostic and therapeutic — improvement within minutes to hours after IM lorazepam 1–2 mg is itself evidence for catatonia.
The lorazepam challenge: diagnostic test and first-line treatment
The single most high-yield manoeuvre in catatonia is the benzodiazepine challenge. The standard protocol used in published series and consensus guidance is intramuscular lorazepam 1–2 mg (IV where a line exists), with the patient observed for response over roughly 15–30 minutes, sometimes repeated or converted to an oral titration (for example up to 10–20 mg/day in divided doses, escalating toward high-dose lorazepam protocols under close monitoring).
Interpreting it:
- Clear improvement in rigidity, posturing, speech or responsiveness supports the diagnosis and justifies continuing benzodiazepine treatment — a positive challenge is diagnostic evidence, not just symptom relief.
- No response after appropriate dosing should prompt reconsideration of the diagnosis, investigation for a medical cause (autoimmune encephalitis, imaging, EEG), and early planning for electroconvulsive therapy.
- Worsening sedation without motor improvement means you are treating drowsiness, not catatonia — reassess.
Where benzodiazepines fail, ECT is the definitive treatment for catatonia, including malignant catatonia, with response rates reported as high as 80–90% in series of ECT for catatonic syndromes. Practical points examiners like: catatonia may require modified/anesthesia-adjusted protocols (higher stimulus requirements are reported because of muscle rigidity), and ECT should not be delayed in malignant presentations. Supportive care runs in parallel — fluid and electrolyte correction, DVT and pressure-area prophylaxis, nutrition, and continuous observation.
Structured practice on this territory — challenge protocols, ECT indications, and the DSM-5 feature list — is drilled repeatedly in Preppsy's MCQ mock exams, where catatonia vignettes tend to appear in precisely the "is this negative symptoms or a motor syndrome" form described above.
Frequently asked questions
How many DSM-5 criteria are needed to diagnose catatonia?
Three or more of the twelve specified features must be present: stupor, catalepsy, waxy flexibility, mutism, negativism, posturing, mannerism, stereotypy, agitation, grimacing, echolalia, and echopraxia. There is no separate duration threshold inside the catatonia criteria themselves — the features must dominate the clinical picture, and you then add the correct code: catatonia associated with another mental disorder, catatonia due to another medical condition, or a course specifier for single versus recurrent episodes.
What is a lorazepam challenge and how do you interpret it?
A lorazepam challenge is the diagnostic-therapeutic test in suspected catatonia: give lorazepam 1–2 mg, typically intramuscularly, and reassess motor symptoms within 15 to 30 minutes. Meaningful improvement in posturing, rigidity, mutism or responsiveness supports the diagnosis and warrants continuing benzodiazepine treatment. No improvement should trigger a medical workup — autoimmune encephalitis, imaging, EEG — and early ECT planning. Failure to respond, or sedation without motor change, argues against straightforward catatonia.
What is malignant catatonia and how does it differ from neuroleptic malignant syndrome?
Malignant catatonia is the severe variant combining catatonic motor features with autonomic instability — fever, tachycardia, blood-pressure lability — and fluctuating consciousness; it carries significant mortality through hyperthermia, rhabdomyolysis and cardiovascular collapse. NMS is best understood as a dopamine-antagonist-triggered, drug-induced form of the same pathophysiology: exposure to a neuroleptic is the distinguishing history. Management converges in both — stop dopamine antagonists, high-dose benzodiazepines, urgent ECT when refractory, and intensive monitoring.
Can catatonia occur in major depression rather than schizophrenia?
Yes. DSM-5 explicitly allows catatonia to be coded as a specifier with depressive disorders and bipolar disorders as well as schizophrenia spectrum disorders — catatonic features such as stupor, mutism and posturing occur in severe melancholic and psychotic depression, historically termed the retarded or agitated subtypes of melancholia. This is why exam vignettes often present an immobile, mute patient with no psychotic-disorder history: the correct answer is catatonia associated with depression, not simply severe depression.
Key takeaways
- 3 of 12: DSM-5 catatonia requires three or more of twelve psychomotor features — memorise the list grouped as stupor spectrum, posture/passivity, repetitive movement, excitement, and imitation.
- Code matters: catatonia can be associated with schizophrenia, mood disorders, or any mental disorder — or be due to a medical condition (stroke, anti-NMDA encephalitis, NMS).
- Lorazepam challenge is diagnostic AND therapeutic: IM 1–2 mg, reassess within 15–30 minutes; response supports the diagnosis and starts treatment.
- ECT is definitive for benzodiazepine-refractory and malignant catatonia, with response rates reported around 80–90%.
- Malignant catatonia is an emergency — autonomic instability plus rigidity means intensive monitoring, not a psychiatric ward alone.
- Under-recognition is the main error: mutism and stupor are constantly mistaken for negative symptoms or depression; test the motor syndrome directly.
If catatonia has been the topic you kept re-reading before exams, turn recognition into recall — walk through the twelve features one last time with Preppsy's MRCPsych study tracks and let the adaptive plan decide what you review tomorrow.
Cover image: “Catatonia: DSM-5 Criteria (cover)” by Preppsy Editorial Team (Original artwork) via Preppsy.
